128 related articles for article (PubMed ID: 12885802)
21. Transrectal ultrasound for staging prostate carcinoma prior to radiation therapy: an evaluation based on disease outcome.
Liebross RH; Pollack A; Lankford SP; Zagars GK; von Eschenbach AC; Geara FB
Cancer; 1999 Apr; 85(7):1577-85. PubMed ID: 10193949
[TBL] [Abstract][Full Text] [Related]
22. Transrectal ultrasound in the staging of clinical T3a prostate cancer.
Hsu CY; Joniau S; Oyen R; Roskams T; Van Poppel H
Eur J Surg Oncol; 2007 Feb; 33(1):79-82. PubMed ID: 17067773
[TBL] [Abstract][Full Text] [Related]
23. Prostate specific antigen detected prostate cancer (clinical stage T1c): an interim analysis.
Lerner SE; Seay TM; Blute ML; Bergstralh EJ; Barrett D; Zincke H
J Urol; 1996 Mar; 155(3):821-6. PubMed ID: 8583584
[TBL] [Abstract][Full Text] [Related]
24. PSA-detected prostate cancer: contrasts with palpable disease.
Matthews GJ; Fracchia JA
J Surg Oncol; 1995 May; 59(1):28-30. PubMed ID: 7538187
[TBL] [Abstract][Full Text] [Related]
25. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H
Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495
[TBL] [Abstract][Full Text] [Related]
26. Is preoperative transrectal ultrasonography of value in localised prostatic carcinoma? A blind comparative study between preoperative transrectal ultrasonography and the histopathological radical prostatectomy specimen.
Vijverberg PL; Giessen MC; Kurth KH; Dabhoiwala NF; de Reijke TM; van den Tweel JG
Eur J Surg Oncol; 1992 Oct; 18(5):449-55. PubMed ID: 1426295
[TBL] [Abstract][Full Text] [Related]
27. Prostate carcinoma patients upstaged by imaging and treated with irradiation. An outcome-based analysis.
Pinover WH; Hanlon A; Lee WR; Kaplan EJ; Hanks GE
Cancer; 1996 Apr; 77(7):1334-41. PubMed ID: 8608512
[TBL] [Abstract][Full Text] [Related]
28. Robotic transrectal ultrasonography during robot-assisted radical prostatectomy.
Hung AJ; Abreu AL; Shoji S; Goh AC; Berger AK; Desai MM; Aron M; Gill IS; Ukimura O
Eur Urol; 2012 Aug; 62(2):341-8. PubMed ID: 22521656
[TBL] [Abstract][Full Text] [Related]
29. Location of Prostate Cancers Determined by Multiparametric and MRI-Guided Biopsy in Patients With Elevated Prostate-Specific Antigen Level and at Least One Negative Transrectal Ultrasound-Guided Biopsy.
Schouten MG; Hoeks CM; Bomers JG; Hulsbergen-van de Kaa CA; Witjes JA; Thompson LC; Rovers MM; Barentsz JO; Fütterer JJ
AJR Am J Roentgenol; 2015 Jul; 205(1):57-63. PubMed ID: 26102380
[TBL] [Abstract][Full Text] [Related]
30. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
[TBL] [Abstract][Full Text] [Related]
31. Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml.
Makarov DV; Humphreys EB; Mangold LA; Walsh PC; Partin AW; Epstein JI; Freedland SJ
J Urol; 2006 Aug; 176(2):554-8. PubMed ID: 16813888
[TBL] [Abstract][Full Text] [Related]
32. Free-to-total prostate specific antigen ratio as a single test for detection of significant stage T1c prostate cancer.
Elgamal AA; Cornillie FJ; Van Poppel HP; Van de Voorde WM; McCabe R; Baert LV
J Urol; 1996 Sep; 156(3):1042-7; discussion 1047-9. PubMed ID: 8709304
[TBL] [Abstract][Full Text] [Related]
33. Do clinically insignificant tumors of the prostate exist?
Stamatiou K; Alevizos A; Mariolis A; Spiliopoulou C; Alevizou A; Bovis K; Sofras F
Urol Int; 2008; 81(4):379-82. PubMed ID: 19077395
[TBL] [Abstract][Full Text] [Related]
34. The incidence of hyperechoic prostate cancer in transrectal ultrasound-guided biopsy specimens.
Spajic B; Eupic H; Tomas D; Stimac G; Kruslin B; Kraus O
Urology; 2007 Oct; 70(4):734-7. PubMed ID: 17991546
[TBL] [Abstract][Full Text] [Related]
35. [Diagnostic value of ultrasound-guided anastomotic biopsies in patients with high PSA (> or = 0,4 ng/ml) after radical prostatectomy].
Scattoni V; Roscigno M; Raber M; Montorsi F; Bertini R; Bua L; Da Pozzo L; Rigatti P
Arch Ital Urol Androl; 2002 Sep; 74(3):129-31. PubMed ID: 12416005
[TBL] [Abstract][Full Text] [Related]
36. [The digital rectal exam, prostate-specific antigen and transrectal echography in the diagnosis of prostatic cancer].
Martínez de Hurtado J; Chéchile Toniolo G; Villavicencio Mavrich H
Arch Esp Urol; 1995 Apr; 48(3):247-59. PubMed ID: 7538749
[TBL] [Abstract][Full Text] [Related]
37. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study.
Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M
Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633
[TBL] [Abstract][Full Text] [Related]
38. Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.
Magheli A; Rais-Bahrami S; Carter HB; Peck HJ; Epstein JI; Gonzalgo ML
J Urol; 2007 Oct; 178(4 Pt 1):1277-80; discussion 1280-1. PubMed ID: 17698121
[TBL] [Abstract][Full Text] [Related]
39. The potential value of power Doppler ultrasound imaging compared with grey-scale ultrasound findings in the diagnosis of local recurrence after radical prostatectomy.
Tamsel S; Killi R; Apaydin E; Hekimgil M; Demirpolat G
Clin Radiol; 2006 Apr; 61(4):325-30; discussion 323-4. PubMed ID: 16546462
[TBL] [Abstract][Full Text] [Related]
40. The role of TRUS-guided biopsies for determination of internal and external spread of prostate cancer.
Lee F; Bahn DK; Siders DB; Greene C
Semin Urol Oncol; 1998 Aug; 16(3):129-36. PubMed ID: 9741417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
